Glancy Prongay & Murray LLP Commences Investigation on Behalf of Stryker Corporation Investors

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Stryker Corporation ("Stryker" or the "Company") SYK investors concerning the Company and its officers' possible violations of federal securities laws. To obtain information or aid in the investigation, please visit the Stryker investigation page on our website at www.glancylaw.com/case/stryker-corporation.

On August 23, 2017, the Company disclosed that it informed the U.S. Food and Drug Administration that it was voluntarily recalling specific lots of the Company's Oral Care products sold through the company's Sage Products business unit. Stryker also stated that the recalled products were distributed between July 2015 and August 2017, and that the recall is being initiated due to potential cross-contamination involving non-pharmaceutical products.

On this news, Stryker's share price fell $7.15 per share, or 4.9%, to close at $138.36 per share on August 23, 2017.

If you purchased Stryker securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170824006229/en/